Background Pulmonary hypertension (PH) is a progressive cardiopulmonary condition associated with increased morbidity and ...

The findings suggest that "the heightened focus on alternative endpoints, now representing the most common primary endpoint, ...

Objectives To identify and assess the social support interventions provided to caregivers of older adults with dementia. By ...

When executed with precision and transparency, ECAs can enhance trial efficiency, expand access and support evidence—while ...

Satri-cel, a CLDN18.2-targeted CAR T-cell therapy, nearly doubles progression-free survival in patients with previously ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad eligibility criteria, and reduced data collection, has quickly answered its primary ...

Molecular predictors of outcome and response to bevacizumab (BEV) based on analysis of RTOG 0825, a phase III trial comparing chemoradiation ... This is an ASCO Meeting Abstract from the 2013 ASCO ...

The objective response rate for LM was 51.6%, including a 15.6% complete response, and the disease control rate was 81.3% by BICR in ... filed with and approved by the Department of Clinical Trial ...

However, few studies have evaluated HaH in a Scandinavian setting, and this article describes the protocol for a randomised controlled trial (RCT) comparing an HaH model with continued conventional in ...